Form 4: Herbalife Director Alan W. LeFevre Reports Acquisition of 18,266 Shares of Common Stock
SEC Form 4 Filing
Director Alan W. LeFevre reports acquiring 18,266 shares of Herbalife Ltd. common stock through restricted stock units.
Summary
- On May 3, 2024, Alan W. LeFevre, a director of Herbalife Ltd., reported acquiring 18,266 shares of common stock.
- The acquisition was in the form of restricted stock units (RSUs) granted under the Herbalife Ltd. 2023 Stock Incentive Plan.
- These RSUs will vest 100% on April 15, 2025, contingent upon continued service on the Issuer's Board of Directors.
- Following the transaction, LeFevre directly owns 69,117 shares of Herbalife Ltd. common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock acquisition through a compensation plan. The acquisition itself can be seen as mildly positive, indicating confidence, but it's not a major event.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.
Future Outlook
The vesting of the RSUs is contingent upon continued service on the Issuer's Board of Directors through April 15, 2025.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's confidence in the company's prospects.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Date of transaction: Alan W. LeFevre acquired 18,266 shares of Herbalife Ltd. common stock. |
| 04/15/2025 | Vesting date for the restricted stock units, contingent upon continued service on the Issuer's Board of Directors. |
| 05/07/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.